Can I leave a clinical trial after signing the consent form?
Yes, at any time, and you do not have to give a reason. The National Cancer Institute states it plainly: even after you sign the consent form, you can leave the study at any time.
This is not a courtesy the study team extends to you. It is federal law. Under 45 CFR 46.116(b)(8), every consent form must tell you that taking part is voluntary, that refusing costs you no benefit you were otherwise entitled to, and that you may stop at any time without penalty or loss of benefits.
Your form already answers most of this
The rule that surprises people is 45 CFR 46.116(c)(4). When relevant, the consent form must describe the consequences of deciding to withdraw, and the procedures for ending your participation in an orderly way. In other words, the answer to "what happens if I quit" is supposed to be written in the document you already signed.
Find that section and read it before you decide. Then ask the study team what an orderly stop looks like in your trial. Some study drugs should not be halted abruptly, and there may be a final safety check or a set of tests to close things out.
One more protection sits in the same regulation. Under 45 CFR 46.116(a)(6), no consent form may contain exculpatory language, meaning wording that makes you waive your legal rights or that releases the investigator, sponsor, or institution from liability for negligence. If a form reads as though you are signing away the right to complain, that is not permitted.
The other direction: being taken off a trial
Leaving is not the only way a trial can end for you. Under 45 CFR 46.116(c)(2), the form must also spell out the situations in which the investigator may end your participation without your consent. That can happen when your disease progresses, when a side effect crosses a set threshold, when you no longer meet the criteria, or when the trial itself is stopped early.
So the honest picture is two-sided. You hold the right to walk away, and the study holds defined rights to stop treating you within the protocol. Both should be in your form.
Consent keeps running after you sign
Signing is a point in a process, not the end of it. You can ask questions at any stage, and the research team must pass on new information as it becomes available. Under 45 CFR 46.116(c)(5), when it applies, the form promises that significant new findings that might change your willingness to continue will be given to you.
That is worth using. If a safety update lands halfway through, you are allowed to reconsider a decision you already made.
What happens to your regular care
Your usual medical care continues outside the trial. Leaving a study does not remove you from your oncologist's practice or from standard treatment for your cancer.
Talk with the team about what you would move to next, and about whether any monitoring should continue for a while after the study drug stops. That conversation is useful, but it is not a condition. The decision is yours. Our guide to informed consent in clinical trials covers what the form must contain, and the piece on your safety in a clinical trial explains who is watching while a study runs.
Sources
Want the full picture? Read our complete explanation: What Is Informed Consent in a Clinical Trial?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.